"Het Universitair Ziekenhuis Antwerpen is een universitair centrum voor topklinische en klantvriendelijke patiëntenzorg, hoogwaardige academische opleiding en grensverleggend wetenschappelijk onderzoek met een belangrijke internationale dimensie. Gespecialiseerde artsen en zorgverleners omringen elke patiënt met een persoonlijke aanpak en innovatieve technieken en behandelingen."

During the past decade, UZ Antwerpen PIN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UZ Antwerpen PIN" are "Dravet Syndrome (DS)" (1 trials) and "Lennox Gastaut Syndrome (LGS)" (1 trials). Many other conditions were trialed in "UZ Antwerpen PIN" in a lesser frequency.

Most popular intervention types in "UZ Antwerpen PIN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "Soticlestat" (2 trials). Other intervention names were less common.

The vast majority of trials in "UZ Antwerpen PIN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UZ Antwerpen PIN". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UZ Antwerpen PIN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UZ Antwerpen PIN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".